30
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multiple endocrinological failures as a clinical presentation of a metastatic lung adenocarcinoma

      research-article
      1 , 2 , 1 , 1 , 1 , 1
      Endocrinology, Diabetes & Metabolism Case Reports
      Bioscientifica Ltd
      Adult, Female, White, France, Tunisia, Adrenal, Hypothalamus, Pituitary, Adrenal, ACTH, Cortisol, Diabetes insipidus - neurogenic/central, Metastatic carcinoma, Adrenal insufficiency, Diabetes insipidus, Polydipsia, Polyuria, Asthenia, Abdominal pain, Hypotension, Hyponatraemia, Nausea, MRI, Water deprivation, CT scan, Histopathology, Adrenal biopsy*, Biopsy, Glucose (blood, fasting), Sodium, Potassium, Urine 24-hour volume, Vasopressin challenge*, Urine osmolality, Serum osmolality, Cortisol (serum), ACTH stimulation, ACTH, PET scan, Vasopressin*, Hydrocortisone, Glucocorticoids, Cisplatin, Pemetrexed, Genetics, Oncology, Urology, Unique/unexpected symptoms or presentations of a disease, April, 2020

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          Multiple endocrine metastases are a rare but possible complication of lung adenocarcinoma (LAC). Pituitary metastasis is a rare condition with poor clinical expression. Diabetes insipidus (DI) is its most common presenting symptom. Here we report an original case of a pituitary stalk (PS) metastasis from LAC presenting as central DI followed by adrenal insufficiency (AI) from bilateral adrenal metastasis, without known evidence of the primary malignancy. A 45-year-old woman whose first clinical manifestations were polyuria and polydipsia was admitted. She was completely asymptomatic with no cough, no weight loss or anorexia. Chest radiography was normal. Brain MRI showed a thick pituitary stalk (PS). DI was confirmed by water restriction test and treated with vasopressin with great clinical results. Explorations for systemic and infectious disease were negative. Few months later, an acute AI led to discovering bilateral adrenal mass on abdominal CT. A suspicious 2.3 cm apical lung nodule was found later. Histopathological adrenal biopsy revealed an LAC. The patient received systemic chemotherapy with hormonal replacement for endocrinological failures by both vasopressin and hydrocortisone. We present this rare case of metastatic PS thickness arising from LAC associated with bilateral adrenal metastasis. Screening of patients with DI and stalk thickness for lung and breast cancer must be considered. Multiple endocrine failures as a diagnostic motive of LAC is a rare but possible circumstance.

          Learning points:
          • Adrenal metastasis is a common location in lung adenocarcinoma; however, metastatic involvement of the pituitary stalk remains a rare occurrence, especially as a leading presentation to diagnose lung cancer.

          • The posterior pituitary and the infundibulum are the preferential sites for metastases, as they receive direct arterial blood supply from hypophyseal arteries.

          • Patients diagnosed with diabetes insipidus due to pituitary stalk thickness should be considered as a metastasis, after exclusion of the classical systemic and infectious diseases.

          • The diagnosis of an endocrinological metastatic primary lung adenocarcinoma for patients without respiratory symptoms is often delayed due to a lack of correlation between endocrinological symptoms and lung cancer.

          • The main originality of our case is the concomitant diagnosis of both endocrinological failures, as it was initiated with a diabetes insipidus and followed by an acute adrenal insufficiency.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Tumors metastatic to the pituitary gland: case report and literature review.

          Tumors metastatic to the pituitary gland are an unusual complication of systemic cancer typically seen in elderly patients with diffuse malignant disease. Breast and lung are the commonest sites of the primary tumor, whereas diabetes insipidus is the most frequent symptom at presentation. Their rarity and usually indolent course, as well as the lack of specific clinical and radiological features, impede their differentiation from other more common sellar area lesions, particularly when history of malignancy is absent. Management of these patients may also be very difficult because the prognosis depends on the course of the primary neoplasm. A 68-yr-old man, with no history of malignancy, presented with recent onset of hypopituitarism, mild diabetes insipidus, headaches, left oculomotor nerve palsy, and progressive bilateral deterioration of visual acuity and visual fields. Magnetic resonance imaging revealed a large sellar mass compressing the optic chiasm and invading the left cavernous sinus, whereas a prolactin elevation at 438.6 ng/ml (19.73 nmol/liter) was noted. Decompression of the sellar region was attempted, and pathology disclosed a metastatic hepatocellular carcinoma. On postoperative investigation, primary liver tumor was identified and confirmed by biopsy. The patient improved transiently but died 3 months after diagnosis because of deterioration of the liver disease. The relevant literature is reviewed in light of this unusual case, illustrating the problems in the diagnosis and management of patients with metastasis to the pituitary.
            • Record: found
            • Abstract: found
            • Article: not found

            Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis.

            To report a rare case of pituitary metastasis (PM) from hepatocellular carcinoma (HCC) and help better understand the incidence of PM and its most common presenting symptoms through a pooled individual patient data analysis.
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Pituitary metastasis: a rare condition

              Tumor metastasis to the pituitary gland is a rare, not well-documented and life-threatening condition associated with a shortened life span. A better understanding of its clinical manifestations could lead to earlier diagnosis, appropriate therapy and potentially improving quality of life. Therefore, we retrospectively studied the charts of patients with pituitary metastases who were treated at the City of Hope National Medical Center (Duarte, CA) from 1984 to 2018. We reviewed and analyzed tumor origin, primary pituitary clinical manifestation, duration between primary tumor diagnosis and pituitary metastasis, type of treatment and patient survival. A total of 11 patients were identified with a mean age of 59.2 years and median survival following the diagnosis of metastasis of 10 months. Breast cancer and lymphoma were the most common primary origins in these cases, and diabetes insipidus and panhypopituitarism were the most common clinical manifestations of their metastasis. We also compared our results with reports in the literature published between 1957 and 2018. A total 289 patients with pituitary metastasis have been reported in the literature. Breast cancer was the most frequent primary origin of the metastasis, and visual symptoms were the most common primary manifestation. The posterior part of the pituitary is more susceptible than the anterior to metastasis. Pituitary metastasis may occur as a consequence of successful primary tumor treatment prolonging the chance of seeding. Future studies are needed to determine the molecular mechanism of metastasis to the pituitary.

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                29 April 2020
                2020
                : 2020
                : 20-0024
                Affiliations
                [1 ]Department of Endocrinology and Diabetology , Douai Hospital Center, Douai, France
                [2 ]Department of Endocrinology , University Hospital of Farhat Hached Sousse, Sousse, Tunisia
                Author notes
                Correspondence should be addressed to A Taieb; Email: ach.taieb@ 123456gmail.com
                Author information
                https://orcid.org/0000-0002-8387-8278
                Article
                EDM200024
                10.1530/EDM-20-0024
                7219154
                853c9b73-4feb-4ec5-9a35-8b417bff9a54
                © 2020 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License..

                History
                : 22 March 2020
                : 07 April 2020
                Categories
                Adult
                Female
                White
                France
                Tunisia
                Adrenal
                Hypothalamus
                Pituitary
                Adrenal
                ACTH
                Cortisol
                Diabetes Insipidus - Neurogenic/Central
                Metastatic Carcinoma
                Adrenal Insufficiency
                Diabetes insipidus
                Polydipsia
                Polyuria
                Asthenia
                Abdominal pain
                Hypotension
                Hyponatraemia
                Nausea
                MRI
                Water deprivation
                CT scan
                Histopathology
                Adrenal biopsy*
                Biopsy
                Glucose (blood, fasting)
                Sodium
                Potassium
                Urine 24-hour volume
                Vasopressin challenge*
                Urine osmolality
                Serum osmolality
                Cortisol (serum)
                ACTH stimulation
                ACTH
                PET scan
                Vasopressin*
                Hydrocortisone
                Glucocorticoids
                Cisplatin
                Pemetrexed
                Genetics
                Oncology
                Urology
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                adult,female,white,france,tunisia,adrenal,hypothalamus,pituitary,acth,cortisol,diabetes insipidus - neurogenic/central,metastatic carcinoma,adrenal insufficiency,diabetes insipidus,polydipsia,polyuria,asthenia,abdominal pain,hypotension,hyponatraemia,nausea,mri,water deprivation,ct scan,histopathology,adrenal biopsy*,biopsy,glucose (blood, fasting),sodium,potassium,urine 24-hour volume,vasopressin challenge*,urine osmolality,serum osmolality,cortisol (serum),acth stimulation,pet scan,vasopressin*,hydrocortisone,glucocorticoids,cisplatin,pemetrexed,genetics,oncology,urology,unique/unexpected symptoms or presentations of a disease,april,2020

                Comments

                Comment on this article

                Related Documents Log